Are you Dr. Takenouchi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
New York, NY 10065Phone+1 212-746-3332Fax+1 212-746-4001
Summary
- Dr. Toshiki Takenouchi, MD is a Child Neurologist in New York, New York. He is currently licensed to practice medicine in Connecticut and Hawaii.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Child Neurology, 2002- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2006 - 2009
Brooklyn Hospital CenterInternship, Transitional Year, 2005 - 2006
Keio Gujuku University School of MedicineClass of 2002
Certifications & Licensure
CT State Medical License 2009 - 2025
HI State Medical License Active through 2014- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 82 citationsNovel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.Toshiki Takenouchi, Yu Yamaguchi, Akiko Tanikawa, Rika Kosaki, Hideyuki Okano
The Journal of Pediatrics. 2015-02-01 - 21 citationsVariants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathyNorine Voisin, Rhonda E. Schnur, Sofia Douzgou, Susan M. Hiatt, Cecilie F. Rustad
American Journal of Human Genetics. 2021-05-06 - 18 citationsSomatic CTNNB1 mutation in hepatoblastoma from a patient with Simpson-Golabi-Behmel syndrome and germline GPC3 mutation.Rika Kosaki, Toshiki Takenouchi, Noriko Takeda, Masayo Kagami, Kazuhiko Nakabayashi
American Journal of Medical Genetics. Part A. 2014-04-01
Press Mentions
Excelra Collaborates with Keio University on Drug Repurposing to Explore New Therapeutics for a Rare IndicationDecember 17th, 2019- Study Touts Rapid Genome Testing in NICUsMarch 4th, 2024
